TDC
ABBV icon

Thompson Davis & Co’s AbbVie ABBV Stock Holding History

Thompson Davis & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,200
Closed -$704K – 103
2021
Q4 		$704K Buy
+5,200
New +$614K 0.59% 23
2018
Q2 		– Sell
-250
Closed -$24K – 663
2018
Q1 		$24K Buy
+250
New +$27.5K 0.06% 268
2017
Q4 		– Sell
-57
Closed -$5K – 659
2017
Q3 		$5K Hold
57
– – 0.01% 839
2017
Q2 		$4K Sell
57
-815
-93% -$54.8K 0.01% 867
2017
Q1 		$57K Buy
872
+175
+25% +$11K 0.08% 229
2016
Q4 		$44K Sell
697
-128
-16% -$7.81K 0.07% 259
2016
Q3 		$52K Sell
825
-445
-35% -$28.8K 0.09% 228
2016
Q2 		$79K Buy
1,270
+390
+44% +$23.8K 0.13% 167
2016
Q1 		$50K Buy
880
+269
+44% +$15K 0.07% 239
2015
Q4 		$36K Hold
611
– – 0.05% 316
2015
Q3 		$33K Buy
611
+530
+654% +$34.5K 0.05% 335
2015
Q2 		$5K Hold
81
– – 0.01% 878
2015
Q1 		$5K Sell
81
-114
-58% -$6.89K 0.01% 882
2014
Q4 		$13K Buy
195
+3
+2% +$189 0.02% 656
2014
Q3 		$11K Buy
+192
New +$10.7K 0.01% 657

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Thompson Davis & Co's ABBV Position: Q1 2022 in Review

Thompson Davis & Co sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 5,200 shares — an estimated $704K sold.

Thompson Davis & Co first reported a position in ABBV in Q3 2014 and held it in 15 quarters. The position peaked at $704K in Q4 2021. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Thompson Davis & Co reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Thompson Davis & Co sold 5,200 AbbVie shares in Q1 2022, an estimated $704K.
  • Thompson Davis & Co first reported a position in AbbVie in Q3 2014 and held it in 15 quarters.
  • Thompson Davis & Co's AbbVie position peaked at $704K in Q4 2021.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Thompson Davis & Co's 13F filing for Q1 2022, filed 13 May 2022.